MedPath

Motion Sickness

Foster and Thrive 44-198

Approved
Approval ID

be8f91d4-6e4f-4d47-93e9-7fb91160b7df

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 8, 2025

Manufacturers
FDA

Strategic Sourcing Services LLC

DUNS: 116956644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dimenhydrinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70677-1087
Application NumberM009
Product Classification
M
Marketing Category
C200263
G
Generic Name
Dimenhydrinate
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2025
FDA Product Classification

INGREDIENTS (7)

DIMENHYDRINATEActive
Quantity: 50 mg in 1 1
Code: JB937PER5C
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Motion Sickness - FDA Drug Approval Details